Pembrolizumab vs Tacrolimus
Pembrolizumab vs Tacrolimus: Overview
This comparison examines the pharmacological differences between Pembrolizumab and Tacrolimus.
Mechanism of Action
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Tacrolimus: Calcineurin inhibitor binding FKBP12; suppresses IL-2 transcription.
Pharmacokinetics
Half-life: Pembrolizumab — 26 days; Tacrolimus — 12 hours.
Chemical Properties
Molecular Formula: Tacrolimus — C44H69NO12.
Molecular Weight: Tacrolimus — 804.0180 g/mol.
Type: Pembrolizumab — Antibody; Tacrolimus — Small molecule.